Cargando…
255. Breakthrough Mucormycosis (BT-MCR) on Antifungals Having Mucorales Activity Portrays Worse Prognosis compared with BT-MCR on Mold-Active Antifungals with no Mucorales Activity
BACKGROUND: BT-MCR is known to develop in the setting of agents having Aspergillus but no Mucorales activity. However, BT-MCR can occur even with the use of antifungals having with Mucorales activity in patients with hematologic malignancies and or stem cell transplant (HM). METHODS: We reviewed the...
Autores principales: | Axell-House, Dierdre B, Jiang, Ying, Kyvernitakis, Andreas, Lewis, Russel E, Raad, Issam I, Kontoyiannis, Dimitrios P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810417/ http://dx.doi.org/10.1093/ofid/ofz360.330 |
Ejemplares similares
-
Breakthrough Mucormycosis Developing on Mucorales-Active Antifungals Portrays a Poor Prognosis in Patients with Hematologic Cancer
por: Axell-House, Dierdre B., et al.
Publicado: (2021) -
2102. Common co-occurence in the respiratory tract of Mucorales with Gram-negative rods in patients with hematologic malignancy and sinopulmonary mucormycosis
por: Egge, Stephanie L, et al.
Publicado: (2022) -
Antifungal-resistant Mucorales in different indoor environments
por: Caetano, Liliana Aranha, et al.
Publicado: (2018) -
Antifungal activity of Taurolidine against Mucorales: An in vitro study on clinical isolates
por: Jafarian, Hadis, et al.
Publicado: (2022) -
Special Issue: Mucorales and Mucormycosis
por: Dannaoui, Eric, et al.
Publicado: (2019)